RxDoctor Payments DataLook up a doctor →

Theodore Vye, DO

Family Medicine · Yakima, WANPI 1609894278

Payments from drug & device makers

$17,293in general payments, 2019–2025

Across 781 payments — averaging $22.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$4K
  • Pfizer$2K
  • AbbVie$2K
  • Boehringer Ingelheim$1K
  • GSK$877
  • Bayer$816
  • plus $7K from 35 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca159$4,283
Pfizer113$2,010
AbbVie(2 entities)77$1,589
Boehringer Ingelheim54$1,191
GSK51$877
Bayer30$816
Novo Nordisk41$715
Johnson & Johnson30$555
Lilly USA, LLC26$553
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)17$481
Abbott18$427
Amgen16$357
Sanofi-aventis U.S. LLC20$330
Astellas Pharma US Inc9$308
Mylan Specialty L.p.13$266
Takeda Pharmaceuticals U.S.A., Inc.13$231
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC11$215
Merz North America, Inc.1$214
Novartis7$191
Dexcom, Inc.3$177
Biohaven Pharmaceutical Holding Company Ltd.9$174
Biohaven Pharmaceuticals, Inc.8$158
Daiichi Sankyo Inc.6$154
Merck6$145
Otsuka America Pharmaceutical, Inc.5$100
Lundbeck LLC4$94
Indivior Inc.5$93
Exact Sciences4$86
MDD US Operations, LLC5$82
Corcept Therapeutics3$65
Axsome Therapeutics, Inc.1$62
Teva Pharmaceuticals USA, Inc.3$47
Kowa Pharmaceuticals America, Inc.3$46
E.r. Squibb & Sons, L.L.C.2$37
Sumitomo Pharma America, Inc.2$37
Vanda Pharmaceuticals Inc.1$30
Gilead1$26
Eisai Inc.1$22
Medtronic1$19
Shire North American Group Inc1$15
Ironwood Pharmaceuticals, Inc1$15

How this compares

$17,293 in reported general payments places this provider in the 95th percentile of 2,275 family medicine providers in Washington.

See all family medicine providers in Washington →

Medicare billing

Part B allowed, 2024
$187,218
Medicare patients
283
Services billed
3,237

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Yakima

See the full list for Washington →

Where these figures come from

Is this you, or does something look wrong? →